Experienced MedTech leader to scale manufacturing, drive European expansion, and position the company to enter the US market with the Kaleido insulin patch pump AID systemUTRECHT, The Netherlands ...
The FDA has approved Medtronic's Brainsense Adaptive deep brain stimulation for patients with Parkinson's disease. The technology is designed to adjust therapy in real time based on a patient's brain ...
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including The Charles Schwab Corp. (SCHW), ...
The latest health news reveals Medtronic's strategic response to U.S. tariffs, WHO's concerns on West Bank violence, mystery ...
Hosted on MSN19h
Medtronic Stock Gets IBD Rating LiftIn a welcome move, Medtronic stock saw its Relative Strength Rating improve from 67 to 73 on Tuesday. Please watch the video ...
The FDA has approved BrainSense, an adaptive deep brain stimulation system that can adjust therapy for Parkinson’s disease in ...
Medtronic (MDT) is reportedly looking at adjusting its global manufacturing footprint amid heightened concerns that the U.S.
The biggest technical challenge for adaptive deep brain stimulation (aDBS) is how small brain signals are, Medtronic's Scott ...
Medical device maker Medtronic is looking at options to modify its global manufacturing footprint as part of efforts to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback